These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 2671764)
41. [Podocyte depletion in children with hepatitis B virus-associated membranous nephropathy]. Zhang Y; Zhou JH; Wang HT Zhonghua Er Ke Za Zhi; 2007 May; 45(5):344-8. PubMed ID: 17697619 [TBL] [Abstract][Full Text] [Related]
42. A case of membranous proliferative glomerulonephritis type III (Burkholder) with the deposition of both HBeAg and HBsAg. Amemiya S; Ito H; Kato K; Sakaguchi H; Hasegawa O; Hajikano H Int J Pediatr Nephrol; 1983 Dec; 4(4):267-73. PubMed ID: 6363317 [TBL] [Abstract][Full Text] [Related]
43. [Glomerulonephropathy associated with hepatitis B virus (HBV) infection]. Zhou WZ; Zhang WL; Geng L Zhonghua Nei Ke Za Zhi; 1990 Sep; 29(9):530-3, 574. PubMed ID: 2086025 [TBL] [Abstract][Full Text] [Related]
44. Resolution of HBV infection occurs sooner than recovery of renal disease in adult serum HBsAg-negative HBV-associated glomerulonephritis. Xu Md F; Wang Md C; Shi Md X; Hou Md J; Guo Md X; Gao Md P J Med Virol; 2018 Sep; 90(9):1503-1507. PubMed ID: 29718537 [TBL] [Abstract][Full Text] [Related]
45. [The clinico-pathological studies of hepatitis B virus nephropathy in adults]. Tadokoro M Nihon Jinzo Gakkai Shi; 1991 Mar; 33(3):257-66. PubMed ID: 2062011 [TBL] [Abstract][Full Text] [Related]
46. Strong association between IgA nephropathy and hepatitis B surface antigenemia in endemic areas. Lai KN; Lai FM; Tam JS; Vallance-Owen J Clin Nephrol; 1988 May; 29(5):229-34. PubMed ID: 3293854 [TBL] [Abstract][Full Text] [Related]
47. Interferon treatment for hepatitis B-associated membranous glomerulonephritis in two Chinese children. Wong SN; Yu EC; Lok AS; Chan KW; Lau YL Pediatr Nephrol; 1992 Sep; 6(5):417-20. PubMed ID: 1280987 [TBL] [Abstract][Full Text] [Related]
48. IgG subclasses in circulating immune complexes with hepatitis B e antigen in chronic hepatitis B. Sällberg M; Norder H; Lindh G; Magnius LO Clin Exp Immunol; 1991 Apr; 84(1):116-21. PubMed ID: 2015701 [TBL] [Abstract][Full Text] [Related]
49. Circulating immune complex in glomerulonephropathy associated with hepatitis B virus infection. Furuse A; Hattori S; Terashima T; Karashima S; Matsuda I Nephron; 1982; 31(3):212-8. PubMed ID: 6214722 [TBL] [Abstract][Full Text] [Related]
50. Membranous nephropathy associated with hepatitis B in Spanish children. Peña A; Débora MJ; Melgosa M; Luz Picazo M; Navarro M Clin Nephrol; 2001 Jan; 55(1):25-30. PubMed ID: 11200864 [TBL] [Abstract][Full Text] [Related]
51. [Membranous nephropathy associated with chronic hepatitis caused by B virus]. Zacchello G; Zancan L; Alberti A; Milanesi C; Rizzoni G; Zacchello F Pediatr Med Chir; 1986; 8(3):311-4. PubMed ID: 2947050 [TBL] [Abstract][Full Text] [Related]
52. Hepatitis B virus-related nephropathy and lupus nephritis: morphologic similarities of two clinical entities. Lai FM; To KF; Wang AY; Choi PC; Szeto CC; Li PK; Leung CB; Lai KN Mod Pathol; 2000 Feb; 13(2):166-72. PubMed ID: 10697274 [TBL] [Abstract][Full Text] [Related]
53. Serum and tissue positivity for hepatitis B virus markers in histopathologically proven glomerulonephropathies. Thyagarajan SP; Thirunalasundari T; Subramanian S; Panchanadam M; Nammalwar BR; Prabha V; Vijayakumar ; Jayaraman M J Med Microbiol; 1989 Aug; 29(4):243-9. PubMed ID: 2547953 [TBL] [Abstract][Full Text] [Related]
54. [The characteristic of T cells response to HBV-specific antigen proteins in patients with HBV infection]. Feng X; Yan HP; Liao HY; Liu YM; Zhang GY; Lin F; Zhao Y; Huang YL Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Aug; 26(4):253-5. PubMed ID: 23189836 [TBL] [Abstract][Full Text] [Related]
55. Replication of hepatitis B virus with corticosteroid therapy in hepatitis B virus related membranous nephropathy. Lai FM; Tam JS; Li PK; Lai KN Virchows Arch A Pathol Anat Histopathol; 1989; 414(3):279-84. PubMed ID: 2494807 [TBL] [Abstract][Full Text] [Related]
56. Hepatitis B virus core and e antigen: immune recognition and use as a vaccine carrier moiety. Schödel F; Peterson D; Milich D Intervirology; 1996; 39(1-2):104-10. PubMed ID: 8957676 [TBL] [Abstract][Full Text] [Related]
57. The secreted hepatitis B precore antigen can modulate the immune response to the nucleocapsid: a mechanism for persistence. Milich DR; Chen MK; Hughes JL; Jones JE J Immunol; 1998 Feb; 160(4):2013-21. PubMed ID: 9469465 [TBL] [Abstract][Full Text] [Related]
58. [Hepatitis B virus, the main cause of membranous nephropathy in China]. Chen G; Zhang Y; Zou W Zhonghua Yi Xue Za Zhi; 1995 Sep; 75(9):540-2, 574-5. PubMed ID: 8556545 [TBL] [Abstract][Full Text] [Related]
59. A sero-epidemiological cross-sectional study of hepatitis B virus in Zimbabwe. Tswana S; Chetsanga C; Nyström L; Moyo S; Nzara M; Chieza L S Afr Med J; 1996 Jan; 86(1):72-5. PubMed ID: 8685787 [TBL] [Abstract][Full Text] [Related]
60. Occult hepatitis B virus infection with positive hepatitis B e antigen. Han Z; Liu Y; Pan J; Bi Y; Liu J; Zhou YH Clin Chim Acta; 2015 Jan; 438():266-8. PubMed ID: 25218700 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]